Compare · COR vs PETQ
COR vs PETQ
Side-by-side comparison of Cencora Inc. (COR) and PetIQ Inc. (PETQ): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both COR and PETQ operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- COR carries a market cap of $68.51B.
- COR has hit the wire 22 times in the past 4 weeks while PETQ has been quiet.
- COR has more recent analyst coverage (25 ratings vs 8 for PETQ).
- Company
- Cencora Inc.
- PetIQ Inc.
- Price
- -
- -
- Market cap
- $68.51B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2017
- News (4w)
- 22
- 0
- Recent ratings
- 25
- 8
Cencora Inc.
CoreSite Realty Corporation (NYSE:COR) delivers secure, reliable, high-performance data center, cloud access and interconnection solutions to a growing customer ecosystem across eight key North American markets. More than 1,375 of the world's leading enterprises, network operators, cloud providers, and supporting service providers choose CoreSite to connect, protect and optimize their performance-sensitive data, applications and computing workloads. Our scalable, flexible solutions and 460+ dedicated employees consistently deliver unmatched data center options  all of which leads to a best-in-class customer experience and lasting relationships.
PetIQ Inc.
PetIQ, Inc. operates as a pet medication and wellness company. It operates in two segments, Products and Services. The company offers Rx pet medications, which include heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and co-develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers across 41 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
Latest COR
- President & CEO Mauch Robert P. was granted 18,292 restricted stock units (SEC Form 4)
- Executive Vice President Campbell Elizabeth S was granted 4,402 restricted stock units (SEC Form 4)
- Chief Financial Officer Boratto Eva C was granted 5,488 restricted stock units (SEC Form 4)
- SVP & Chief Accounting Officer Krikorian Lazarus was granted 3,216 restricted stock units (SEC Form 4)
- EVP, Chief Data & Info Officer Verma Pawan was granted 4,231 restricted stock units (SEC Form 4)
- President & CEO Mauch Robert P. converted options into 40,271 shares and covered exercise/tax liability with 17,405 shares, increasing direct ownership by 34% to 90,652 units (SEC Form 4) (tax liability)
- SVP & Chief Accounting Officer Krikorian Lazarus converted options into 3,386 shares and covered exercise/tax liability with 1,457 shares, increasing direct ownership by 13% to 16,948 units (SEC Form 4) (withholding tax)
- Executive Vice President Campbell Elizabeth S converted options into 17,190 shares and covered exercise/tax liability with 7,947 shares, increasing direct ownership by 45% to 29,682 units (SEC Form 4) (for withholding tax)
- EVP, Chief Data & Info Officer Verma Pawan converted options into 1,321 shares and covered exercise/tax liability with 676 shares, increasing direct ownership by 7% to 10,077 units (SEC Form 4) to satisfy tax liability
- President & CEO Mauch Robert P. converted options into 4,066 shares and covered exercise/tax liability with 1,673 shares, increasing direct ownership by 4% to 67,786 units (SEC Form 4) (for withholding tax)
Latest PETQ
- PetIQ Names Camillo Pane as Chief Executive Officer
- Amendment: SEC Form SC 13G/A filed by PetIQ Inc.
- Amendment: SEC Form SC 13G/A filed by PetIQ Inc.
- SEC Form 15-12G filed by PetIQ Inc.
- Amendment: SEC Form SC 13G/A filed by PetIQ Inc.
- Amendment: SEC Form SC 13G/A filed by PetIQ Inc.
- Chief Financial Officer Glasman Zvi returned 25,800 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Huff Scott returned 6,077 shares to the company, closing all direct ownership in the company (SEC Form 4)
- EVP Manufacturing & Sup. Chain Lyon Chad D. returned 10,659 shares to the company, closing all direct ownership in the company (SEC Form 4)
- EVP, GENERAL COUNSEL Carter William J. returned 3,497 shares to the company, closing all direct ownership in the company (SEC Form 4)